NajmosamaNikruiMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Mass Gen Hosp
Dr. Nikrui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 S Huntington Ave
Boston, MA 02130Phone+1 857-364-4841Fax+1 857-364-6866
Education & Training
Maimonides Medical Center/SUNY Downstate HSUFellowship, Gynecologic Oncology, 1972 - 1975- SUNY Downstate Health Sciences UniversityResidency, Obstetrics and Gynecology, 1969 - 1973
New York Medical College (Sound Shore)Residency, Surgery, 1969 - 1969
Albert Einstein College of Medicine/Montefiore (New Rochelle)Internship, Transitional Year, 1968 - 1968
Shiraz University of Medical SciencesClass of 1967
Certifications & Licensure
MA State Medical License 1976 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 21 citationsTen-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial o...Gisele Sarosy, Mahrukh M. Hussain, Michael V. Seiden, Arlan F. Fuller, Najmosama Nikrui
Cancer. 2010-03-15 - 141 citationsCytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.Richard T. Penson, Kate Kronish, Zhenfeng Duan, Aynn J. Feller, Paul Stark
International Journal of Gynecological Cancer. 2000-01-19 - 271 citationsClear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.Barbara A. Goff, Ricardo Sainz de la Cuesta, Howard G. Muntz, D. Fleischhacker, Marit Ek
Gynecologic Oncology. 1996-03-01
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- Farsi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
